By Editor , 6 October 2026
AMPERA Files NRC Engagement Plan for Thorium Microreactor

Palm Beach Gardens, Fla. – October 05, 2026 -- AMPERA has submitted a comprehensive Regulatory Engagement Plan to the U.S. Nuclear Regulatory Commission, with plans to file its combined manufacturing and fuel fabrication facility license application by October 2027.

By Editor , 5 October 2026

Salt Lake City – October 05, 2026 -- Glacis Technologies Inc. has signed a memorandum of understanding with Utah's Office of Artificial Intelligence Policy (OAIP) that makes cryptographically signed AI "receipts" a mandatory condition for vendors and systems operating in the state's Artificial Intelligence Learning Laboratory.

By Editor , 5 October 2026
AIRS Medical Wins FDA Clearance for 5-Minute MRI Body Composition Tool

Chicago – October 05, 2026 -- AIRS Medical has secured U.S. FDA 510(k) clearance for SwiftSight Body Composition, an AI-powered MRI analysis tool that quantifies muscle and fat tissue in under five minutes, with SimonMed Imaging confirmed as the first customer to deploy the system.

By Editor , 5 October 2026
MobileFuse Secures SBTi Validation for 2030 Emissions Target

New York – October 05, 2026 -- MobileFuse has secured validation from SBTi Services for a science-based greenhouse gas emissions reduction target, committing the advertising technology company to maintain zero Scope 1 and Scope 2 emissions through 2030.

By Editor , 5 October 2026
Talkiatry Earns Joint Commission Gold Seal for Behavioral Health

New York – October 05, 2026 -- Talkiatry, the largest psychiatric provider group in the U.S., has received The Joint Commission's Gold Seal of Approval® for Behavioral Health, covering care delivered to more than 170 million lives nationwide.

By Editor , 5 October 2026
HanchorBio Wins FDA IND Clearance for Trispecific Drug HCB303

Taipei, Shanghai and San Francisco – October 05, 2026 -- HanchorBio, Inc. (TWSE: 7827) said the U.S. Food and Drug Administration has cleared the investigational new drug application for HCB303, clearing the path for the company's second trispecific immunotherapy to enter human testing.

By Editor , 5 October 2026

Helsinki – October 05, 2026 -- UPM-Kymmene Corporation and Sappi have received a Letter of Facts from the European Commission restating serious concerns about their proposed graphic paper Joint Venture, the companies disclosed as inside information on October 5, 2026.

By Editor , 5 October 2026
Temu, Italy's ICQRF Sign MoU to Protect Geographical Indications Online

Rome – October 05, 2026 -- Temu has signed a Memorandum of Understanding with Italy's Central Inspectorate for Fraud Repression and Quality Protection of Agri-Food Products (ICQRF) to strengthen protection of Geographical Indications (GIs) on its online marketplace.

By Editor , 5 October 2026
ICAC, UNODC Launch First Global Anti-Corruption Guide for Prisons

Abu Dhabi – October 05, 2026 -- Hong Kong's Independent Commission Against Corruption (ICAC) and the United Nations Office on Drugs and Crime (UNODC) jointly launched the first global guidebook on corruption risk management in prison systems, unveiled on October 1 at the 15th United Nations Congress on Crime Prevention and Criminal Justice in Abu Dhabi.

By Editor , 3 October 2026
Silvercorp Shareholders Approve Hong Kong Listing-Aligned Article Changes

Vancouver – October 02, 2026 -- Silvercorp Metals Inc. (TSX/NYSE American: SVM) secured shareholder approval for all resolutions at its annual general and special meeting, including a special resolution to amend its corporate Articles to align with Hong Kong Stock Exchange listing rules.